Role of monoclonal antibodies in the treatment of immune-mediated glomerular diseases
Papel de los anticuerpos monoclonales en el tratamiento de las enfermedades glomerulares autoinmunes
Read
15869
Timeswas read the article
3412
Total PDF
12457
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 7 | 18 | 4 | 22 |
| 2025 6 | 224 | 201 | 425 |
| 2025 5 | 144 | 48 | 192 |
| 2025 4 | 99 | 23 | 122 |
| 2025 3 | 161 | 79 | 240 |
| 2025 2 | 129 | 47 | 176 |
| 2025 1 | 105 | 31 | 136 |
| 2024 12 | 97 | 32 | 129 |
| 2024 11 | 104 | 56 | 160 |
| 2024 10 | 95 | 35 | 130 |
| 2024 9 | 84 | 26 | 110 |
| 2024 8 | 83 | 66 | 149 |
| 2024 7 | 82 | 26 | 108 |
| 2024 6 | 114 | 59 | 173 |
| 2024 5 | 105 | 40 | 145 |
| 2024 4 | 73 | 119 | 192 |
| 2024 3 | 86 | 25 | 111 |
| 2024 2 | 69 | 41 | 110 |
| 2024 1 | 54 | 22 | 76 |
| 2023 12 | 84 | 59 | 143 |
| 2023 11 | 76 | 49 | 125 |
| 2023 10 | 137 | 42 | 179 |
| 2023 9 | 111 | 34 | 145 |
| 2023 8 | 68 | 31 | 99 |
| 2023 7 | 111 | 28 | 139 |
| 2023 6 | 82 | 23 | 105 |
| 2023 5 | 78 | 31 | 109 |
| 2023 4 | 75 | 14 | 89 |
| 2023 3 | 83 | 22 | 105 |
| 2023 2 | 65 | 16 | 81 |
| 2023 1 | 57 | 30 | 87 |
| 2022 12 | 87 | 41 | 128 |
| 2022 11 | 77 | 25 | 102 |
| 2022 10 | 87 | 42 | 129 |
| 2022 9 | 65 | 50 | 115 |
| 2022 8 | 70 | 41 | 111 |
| 2022 7 | 65 | 60 | 125 |
| 2022 6 | 58 | 38 | 96 |
| 2022 5 | 73 | 31 | 104 |
| 2022 4 | 99 | 48 | 147 |
| 2022 3 | 111 | 71 | 182 |
| 2022 2 | 90 | 51 | 141 |
| 2022 1 | 120 | 34 | 154 |
| 2021 12 | 125 | 40 | 165 |
| 2021 11 | 103 | 41 | 144 |
| 2021 10 | 111 | 35 | 146 |
| 2021 9 | 65 | 47 | 112 |
| 2021 8 | 87 | 47 | 134 |
| 2021 7 | 86 | 34 | 120 |
| 2021 6 | 63 | 31 | 94 |
| 2021 5 | 90 | 38 | 128 |
| 2021 4 | 175 | 79 | 254 |
| 2021 3 | 82 | 49 | 131 |
| 2021 2 | 119 | 18 | 137 |
| 2021 1 | 83 | 28 | 111 |
| 2020 12 | 66 | 18 | 84 |
| 2020 11 | 52 | 24 | 76 |
| 2020 10 | 54 | 26 | 80 |
| 2020 9 | 68 | 12 | 80 |
| 2020 8 | 51 | 19 | 70 |
| 2020 7 | 64 | 17 | 81 |
| 2020 6 | 73 | 28 | 101 |
| 2020 5 | 88 | 24 | 112 |
| 2020 4 | 60 | 11 | 71 |
| 2020 3 | 83 | 20 | 103 |
| 2020 2 | 74 | 23 | 97 |
| 2020 1 | 72 | 16 | 88 |
| 2019 12 | 84 | 21 | 105 |
| 2019 11 | 72 | 28 | 100 |
| 2019 10 | 66 | 18 | 84 |
| 2019 9 | 71 | 26 | 97 |
| 2019 8 | 93 | 20 | 113 |
| 2019 7 | 70 | 30 | 100 |
| 2019 6 | 75 | 42 | 117 |
| 2019 5 | 69 | 25 | 94 |
| 2019 4 | 124 | 50 | 174 |
| 2019 3 | 97 | 25 | 122 |
| 2019 2 | 51 | 21 | 72 |
| 2019 1 | 62 | 26 | 88 |
| 2018 12 | 117 | 48 | 165 |
| 2018 11 | 126 | 22 | 148 |
| 2018 10 | 107 | 14 | 121 |
| 2018 9 | 122 | 18 | 140 |
| 2018 8 | 158 | 29 | 187 |
| 2018 7 | 75 | 18 | 93 |
| 2018 6 | 97 | 20 | 117 |
| 2018 5 | 107 | 12 | 119 |
| 2018 4 | 135 | 19 | 154 |
| 2018 3 | 89 | 6 | 95 |
| 2018 2 | 68 | 12 | 80 |
| 2018 1 | 74 | 8 | 82 |
| 2017 12 | 94 | 14 | 108 |
| 2017 11 | 100 | 30 | 130 |
| 2017 10 | 91 | 7 | 98 |
| 2017 9 | 70 | 13 | 83 |
| 2017 8 | 76 | 8 | 84 |
| 2017 7 | 82 | 11 | 93 |
| 2017 6 | 97 | 14 | 111 |
| 2017 5 | 106 | 10 | 116 |
| 2017 4 | 78 | 18 | 96 |
| 2017 3 | 67 | 5 | 72 |
| 2017 2 | 150 | 11 | 161 |
| 2017 1 | 66 | 8 | 74 |
| 2016 12 | 127 | 12 | 139 |
| 2016 11 | 175 | 19 | 194 |
| 2016 10 | 202 | 20 | 222 |
| 2016 9 | 235 | 6 | 241 |
| 2016 8 | 254 | 14 | 268 |
| 2016 7 | 262 | 18 | 280 |
| 2016 6 | 171 | 0 | 171 |
| 2016 5 | 193 | 0 | 193 |
| 2016 4 | 195 | 0 | 195 |
| 2016 3 | 125 | 0 | 125 |
| 2016 2 | 176 | 0 | 176 |
| 2016 1 | 173 | 0 | 173 |
| 2015 12 | 164 | 0 | 164 |
| 2015 11 | 137 | 0 | 137 |
| 2015 10 | 138 | 0 | 138 |
| 2015 9 | 121 | 0 | 121 |
| 2015 8 | 98 | 0 | 98 |
| 2015 7 | 118 | 0 | 118 |
| 2015 6 | 61 | 0 | 61 |
| 2015 5 | 80 | 0 | 80 |
| 2015 4 | 17 | 0 | 17 |
Show all
